The future of pulsed field ablation (PFA) technology could go in the direction of high-voltage nanosecond energy bursts, ...

A novel pulsed field ablation technology was safe and prevented atrial arrhythmia recurrence in most patients with paroxysmal ...

Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 10 best biotech stocks with highest upside potential. On April 2, Beam ...

Fulcrum Therapeutics (NASDAQ:FULC) highlighted new clinical and corporate progress during its first-quarter 2026 financial results and business update call, with management emphasizing positive Phase ...

Presented positive clinical data for pociredir, demonstrating robust and rapid fetal hemoglobin (HbF) induction, improvements in markers of hemolysis and anemia, and encouraging trends in vaso-occlusi ...

Shares of the company rose 2.81% in pre-market trading following the results. The company presented positive clinical data for pociredir during the quarter, demonstrating robust fetal hemoglobin ...

Presented positive clinical data for pociredir, demonstrating robust and rapid fetal hemoglobin (HbF) induction, improvements in markers of ...

Presented positive clinical data for pociredir, demonstrating robust and rapid fetal hemoglobin (HbF) induction, improvements in markers of hemolysis and anemia, and encouraging trends in vaso-occlusi ...

Researchers have used supercomputers to model how red blood cells deform and become damaged in mechanical circulatory support devices, such as blood pumps used for heart failure patients. The study ...

Mild traumatic brain injury (mTBI) accounts for most head injury emergency department (ED) presentations, yet only a minority of patients have acute ...

Scandinavian Real Heart today announced a new in vitro study backs its Realheart total artificial heart (TAH) system.

Scandinavian Real Heart AB (publ) announces today that a new in vitro study, published in the peer-reviewed journal Artificial Organs, demonstrates that the Realheart® TAH causes approximately half ...